Optimization of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
Henry Chubb, Shadman Aziz, Rashed Karim, Christian Sohns, Orod Razeghi, Steven E Williams, John Whitaker, James Harrison, Amedeo Chiribiri, Tobias Schaeffter, Matthew Wright, Mark O'Neill, Reza Razavi, Henry Chubb, Shadman Aziz, Rashed Karim, Christian Sohns, Orod Razeghi, Steven E Williams, John Whitaker, James Harrison, Amedeo Chiribiri, Tobias Schaeffter, Matthew Wright, Mark O'Neill, Reza Razavi
Abstract
Background: Cardiovascular magnetic resonance (CMR) imaging may be used to visualize post-ablation atrial scar (PAAS), and three-dimensional late gadolinium enhancement (3D LGE) is the most widely employed technique for imaging of chronic scar. Detection of PAAS provides a unique non-invasive insight into the effects of the ablation and may help guide further ablation procedures. However, there is evidence that PAAS is often not detected by CMR, implying a significant sensitivity problem, and imaging parameters vary between leading centres. Therefore, there is a need to establish the optimal imaging parameters to detect PAAS.
Methods: Forty subjects undergoing their first pulmonary vein isolation procedure for AF had detailed CMR assessment of atrial scar: one scan pre-ablation, and two scans post-ablation at 3 months (separated by 48 h). Each scan session included ECG- and respiratory-navigated 3D LGE acquisition at 10, 20 and 30 min post injection of a gadolinium-based contrast agent (GBCA). The first post-procedural scan was performed on a 1.5 T scanner with standard acquisition parameters, including double dose (0.2 mmol/kg) Gadovist and 4 mm slice thickness. Ten patients subsequently underwent identical scan as controls, and the other 30 underwent imaging with a reduced, single, dose GBCA (n = 10), half slice thickness (n = 10) or on a 3 T scanner (n = 10). Apparent signal-to-noise (aSNR), contrast-to-noise (aCNR) and imaging quality (Likert Scale, 3 independent observers) were assessed. PAAS location and area (%PAAS scar) were assessed following manual segmentation. Atrial shells with standardised %PAAS at each timepoint were then compared to ablation lesion locations to assess quality of scar delineation.
Results: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. Likert scale of imaging quality had high interobserver and intraobserver intraclass correlation coefficients (0.89 and 0.96 respectively), and showed lower overall imaging quality on 3 T and at half-slice thickness. aCNR, and quality of scar delineation increased significantly with time. aCNR was higher with reduced, single, dose of GBCA (p = 0.005).
Conclusion: 3D LGE CMR atrial scar imaging, as assessed qualitatively and quantitatively, improves with time from GBCA administration, with some indices continuing to improve from 20 to 30 min. Imaging should be performed at least 20 min post-GBCA injection, and a single dose of contrast should be considered.
Trial registration: Trial registry- United Kingdom National Research Ethics Service 08/H0802/68 - 30th September 2008.
Keywords: Atrial fibrillation; Atrium; Cardiovascular magnetic resonance imaging; Catheter ablation; Late gadolinium enhancement; Optimization.
Conflict of interest statement
Authors’ informationNo third parties were involved in the authorship of review of the manuscript.
Ethics approval and consent to participateForty subjects provided written and informed consent and the study was approved by the National Research Ethics Service (South London Research Ethics Committee reference 08/H0802/68)- 30th September 2008.
Consent for publicationPatient information sheet and consent form included provision for consent for publication (08/H0802/68). All data presented in this article is non-identifiable.
Competing interestsThe authors declare that they have no competing interests.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen S-A, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606. doi: 10.1093/europace/eus027.
- Akoum N, Wilber D, Hindricks G, Jais P, Cates J, Marchlinski F, et al. MRI assessment of ablation-induced scarring in atrial fibrillation: analysis from the DECAAF study. J Cardiovasc Electrophysiol. 2015;26:473–480. doi: 10.1111/jce.12650.
- Badger TJ, Daccarett M, Akoum NW, Adjei-Poku YA, Burgon NS, Haslam TS, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ. Arrhythm. Electrophysiol. 2010;3:249–259. doi: 10.1161/CIRCEP.109.868356.
- Fukumoto K, Habibi M, Gucuk Ipek E, Khurram IM, Zimmerman SL, Zipunnikov V, et al. Comparison of preexisting and ablation-induced late gadolinium enhancement on left atrial magnetic resonance imaging. Heart Rhythm. 2015;12:668–672. doi: 10.1016/j.hrthm.2014.12.021.
- Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007;243:690–695. doi: 10.1148/radiol.2433060417.
- McGann CJ, Kholmovski EG, Oakes RS, Blauer JJEE, Daccarett M, Segerson N, et al. New magnetic resonance imaging-based method for defining the extent of left Atrial Wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008;52:1263–1271. doi: 10.1016/j.jacc.2008.05.062.
- Bisbal F, Guiu E, Cabanas-Grandío P, Berruezo A, Prat-Gonzalez S, Vidal B, et al. CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure. JACC Cardiovasc Imaging. 2014;7:653–663. doi: 10.1016/j.jcmg.2014.01.014.
- Hunter RJ, Jones DA, Boubertakh R, Malcolme-Lawes LC, Kanagaratnam P, Juli CF, et al. Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience. J Cardiovasc Electrophysiol. 2013;24:396–403. doi: 10.1111/jce.12063.
- Harrison JL, Sohns C, Linton NW, Karim R, Williams SE, Rhode KS, et al. Repeat left atrial catheter ablation: cardiac magnetic resonance prediction of endocardial voltage and gaps in ablation lesion sets. Circ Arrhythmia Electrophysiol. 2015;8:270–278. doi: 10.1161/CIRCEP.114.002066.
- Malcolme-Lawes LC, Juli C, Karim R, Bai W, Quest R, Lim PB, et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Heart Rhythm. 2013;10:1184–1191. doi: 10.1016/j.hrthm.2013.04.030.
- Taclas JE, Nezafat R, Wylie JV, Josephson ME, Hsing J, Manning WJ, et al. Relationship between intended sites of RF ablation and post-procedural scar in AF patients, using late gadolinium enhancement cardiovascular magnetic resonance. Heart Rhythm. 2010;7:489–496. doi: 10.1016/j.hrthm.2009.12.007.
- Kuck K-H, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-German atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol. 2016;9:e003337. doi: 10.1161/CIRCEP.115.003337.
- Harrison JL, Jensen HK, Peel SA, Chiribiri A, Grøndal AK, Bloch LØ, et al. Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: a histological validation study. Eur Heart J. 2014;35:1486–1495. doi: 10.1093/eurheartj/eht560.
- Ranjan R, Kholmovski EG, Blauer J, Vijayakumar S, Volland NA, Salama ME, et al. Identification and acute targeting of gaps in atrial ablation lesion sets using a real-time magnetic resonance imaging system. Circ Arrhythm Electrophysiol. 2012;5:1130–1135. doi: 10.1161/CIRCEP.112.973164.
- Peters DC, Wylie JV, Hauser TH, Nezafat R, Han Y, Woo JJ, et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging. 2009;2:308–316. doi: 10.1016/j.jcmg.2008.10.016.
- Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9:2003–2009. doi: 10.1016/j.hrthm.2012.08.039.
- Cappato R, Negroni S, Pecora D, Bentivegna S, Lupo PP, Carolei A, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003;108:1599–1604. doi: 10.1161/01.CIR.0000091081.19465.F1.
- Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506. doi: 10.1001/jama.2014.3.
- Kowalski M, Grimes MM, Perez FJ, Kenigsberg DN, Koneru J, Kasirajan V, et al. Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol. 2012;59:930–938. doi: 10.1016/j.jacc.2011.09.076.
- Josephson ME, Anter E. Substrate mapping for ventricular tachycardia assumptions and misconceptions. JACC Clin Electrophysiol. 2015;1:341–352. doi: 10.1016/j.jacep.2015.09.001.
- Tung R, Kim S, Yaghisita D, Veschi M, Ennis D, Oudah S, et al. Scar voltage threshold determination using ex vivo MRI integration in a porcine infarct model: influence of inter-electrode distances and 3-D spatial effects of scar. Heart Rhythm. 2016;13:1993–2002. doi: 10.1016/j.hrthm.2016.07.003.
- Dabir D, Child N, Kalra A, Mahmoud IZ, Rogers T, Gebker R, et al. Age-gender normal values of native and post-contrast myocardial T1 relaxation times (lambda) on 1.5T and 3T using MOLLI: a multicenter, single vendor cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16:P23. doi: 10.1186/1532-429X-16-S1-P23.
- Kolbitsch C, Prieto C, Smink J, Schaeffter T. Highly efficient whole-heart imaging using radial phase encoding-phase ordering with automatic window selection. Magn Reson Med. 2011;66:1008–1018. doi: 10.1002/mrm.22888.
- Benito EM, Carlosena-Remirez A, Guasch E, Prat-González S, Perea RJ, Figueras R, et al. Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility. Europace. 2017;19(8):1272–9. 10.1093/europace/euw219.
- Okumura Y, Watanabe I, Iso K, Nagashima K, Sonoda K, Sasaki N, et al. Clinical utility of automated ablation lesion tagging based on catheter stability information (VisiTag module of the CARTO 3 system) with contact force-time integral during pulmonary vein isolation for atrial fibrillation. J Interv Card Electrophysiol. 2016;47:245–252. doi: 10.1007/s10840-016-0156-z.
- Crum WR, Camara O, Hill DLG. Generalized overlap measures for evaluation and validation in medical image analysis. IEEE Trans Med Imaging. 2006;25:1451–1461. doi: 10.1109/TMI.2006.880587.
- McGraw KO, Wong SP. Forming inferences about some intraclass correlations coefficients. Psychol Methods. 1996;1:390. doi: 10.1037/1082-989X.1.4.390.
- Goldfarb JW, Arnold S, Roth M. Gadolinium pharmacokinetics of chronic myocardial infarcts: implications for late gadolinium-enhanced infarct imaging. J Magn Reson Imaging. 2009;30:763–770. doi: 10.1002/jmri.21901.
- Platonov PG, Ivanov V, Ho SY, Mitrofanova L. Left atrial Posterior Wall thickness in patients with and without atrial fibrillation: data from 298 consecutive autopsies. J Cardiovasc Electrophysiol. 2008;19:689–692. doi: 10.1111/j.1540-8167.2008.01102.x.
- Khurram IM, Beinart R, Zipunnikov V, Dewire J, Yarmohammadi H, Sasaki T, et al. Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis. Heart Rhythm. 2014;11:85–92. doi: 10.1016/j.hrthm.2013.10.007.
- Fukumoto K, Habibi M, Ipek EG, Zahid S, Khurram IM, Zimmerman SL, et al. Association of Left Atrial Local Conduction Velocity with late gadolinium enhancement on cardiac magnetic resonance in patients with atrial fibrillation. Circ. Arrhythmia Electrophysiol. 2016;9:1–7. doi: 10.1161/CIRCEP.115.002897.
- Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, et al. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. doi: 10.1186/1532-429X-15-105.
- Knowles BR, Batchelor PG, Parish V, Ginks M, Plein S, Razavi R, et al. Pharmacokinetic modeling of delayed gadolinium enhancement in the myocardium. Magn Reson Med. 2008;60:1524–1530. doi: 10.1002/mrm.21767.
- Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Investig Radiol. 2005;40:715–724. doi: 10.1097/01.rli.0000184756.66360.d3.
- Sohns C, Karim R, Harrison JL, Arujuna A, Linton N, Sennett R, et al. Quantitative magnetic resonance imaging analysis of the relationship between contact force and left atrial scar formation after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):138–45. 10.1111/jce.12298.
- Halbfass PM, Mitlacher M, Turschner O, Brachmann J, Mahnkopf C. Lesion formation after pulmonary vein isolation using the advance cryoballoon and the standard cryoballoon: lessons learned from late gadolinium enhancement magnetic resonance imaging. Europace. 2015;17:566–573. doi: 10.1093/europace/euu260.
- Higuchi K, Akkaya M, Koopmann M, Blauer JJE, Burgon NS, Damal K, et al. The effect of fat pad modification during ablation of atrial fibrillation: late gadolinium enhancement MRI analysis. Pacing Clin Electrophysiol. 2013;36:467–476. doi: 10.1111/pace.12084.
- Das M, Wynn GJ, Saeed Y, Gomes S, Morgan M, Ronayne C, et al. Pulmonary vein re-isolation as a routine strategy regardless of symptoms: the PRESSURE randomized controlled trial. JACC Clin Electrophysiol. 2017;3:602–611. doi: 10.1016/j.jacep.2017.01.016.
- Zahid S, Whyte KN, Schwarz EL, Blake RC, Boyle PM, Chrispin J, et al. Feasibility of using patient-specific models and the “minimum cut” algorithm to predict optimal ablation targets for left atrial flutter. Heart Rhythm. 2016;13:1687–1698. doi: 10.1016/j.hrthm.2016.04.009.
- Badger TJ, Oakes RS, Daccarett M, Burgon NS, Akoum N, Fish EN, et al. Temporal left atrial lesion formation after ablation of atrial fibrillation. Heart Rhythm. 2009;6:161–168. doi: 10.1016/j.hrthm.2008.10.042.
- Lancelot E. Revisiting the pharmacokinetic profiles of gadolinium-based contrast agents. Investig Radiol. 2016;51:691–700. doi: 10.1097/RLI.0000000000000280.
Source: PubMed